stem cell therapy (BresaGen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namestem cell therapy (BresaGen)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Ectodermal stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/Indicationsbeta-ThalassemiaSpinal Cord InjuriesStroke +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesHospira Adelaide Pty Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHospira Adelaide Pty Ltd

Active IndicationsN/A

Inactive Indicationsbeta-ThalassemiaSpinal Cord InjuriesStroke +[4]

Other Information

ATC CodeN/A